World Evaluation News Today

Real-world evidence from the AHA Scientific Sessions 2023 demonstrated that Eko's AI doubles valvular heart disease detection sensitivity over traditional methods

Advances in artificial intelligence have enabled the development and application of AI tools that may be effective at detecting heart valvular disease and predicting the risk of cardiovascular disease events, according to preliminary research in two studies to be presented at the American Heart Association's Scientific Sessions 2023.

Artificial intelligence (AI) and deep learning models may help to predict the risk of cardiovascular disease events and detect heart valvular disease, according to two preliminary research studies. 

Leading providers join forces to help employers make mental health services more readily available to employees filing disability claims ... | June 14, 2023

SEDGEFIELD MedTech company PolyPhotonix has secured a $10m investment deal with US company Prevail InfoWorks to undertake clinical trials in the…

PolyPhotonix Secures Multimillion Pound US Investment and Strategic Alliance for Sight Saving MaskUK, January 20 2022 - PolyPhotonix Limited, developer of a patented noninvasive treatment for diabetic retinopathy, has entered a global strategic alliance with Prevail InfoWorks, Inc. to lead management of FDA reg...

/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...

/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...